Top Biotechs at ASCO: Ruthie Davi on AI and Data Insights in Platinum-Resistant Ovarian Cancer

In this episode of Top Biotechs at ASCO, Ruthie Davi, Senior Vice President at Medidata Solutions, shares how historical clinical trial data and AI-powered tools are reshaping cancer research and trial design. ✅ New analysis on platinum-resistant ovarian cancer post-PARP inhibitors ✅ Real-world applications of AI in oncology, including HER2-low detection and activity monitoring ✅ Introduction to Protocol Optimizer, a simulation tool for optimizing trial design before execution ✅ How Medidata’s data-sharing program leverages Rave to generate actionable insights across trials ✅ Use of historical data to build external control arms and improve efficiency in severe disease trials From enhancing protocol efficiency to enabling patient-centric innovation, this conversation offers a glimpse into the future of oncology research powered by data and technology. #TopBiotechsAtASCO #ASCO2025 #Medidata #RuthieDavi #ClinicalTrials SUBSCRIBE to get the latest #oncodaily    / @oncodailytv   Visit the OncoDaily Website : https://oncodaily.com Like OncoDaily on LinkedIn:   / oncodaily   Like OncoDaily on X (Twitter): https://x.com/oncodaily Follow OncoDaily on Instagram:   / oncodailynews   Follow OncoDaily on TikTok:   / oncodaily   Like OncoDaily on Facebook:   / oncodaily   SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter About OncoDaily OncoDaily is your trusted source for the latest oncology news, expert interviews, patient stories, and cutting-edge research. Our mission is to empower the global cancer community—patients, survivors, professionals, and advocates—with timely, credible information. Subscribe for weekly podcasts, expert conversations, and updates on groundbreaking cancer research. 🔔 New videos every day! 💻 Visit us at https://oncodaily.com/